News Column

LED Medical Diagnostics Begins Trading on OTCQX(R)

Feb 26 2013 12:00AM

Marketwire

LogoTracker

BURNABY, BRITISH COLUMBIA and NEW YORK, NEW YORK -- (Marketwire) -- 02/26/13 -- LED Medical Diagnostics Inc. (TSX VENTURE: LMD)(OTCQX: LEDIF)(FRANKFURT: LME) ("LED Medical", "the Company"), a developer of tissue visualization detection technologies for the medical industry, is pleased to announce that today it began trading on the OTCQX International (symbol: "LEDIF"), a segment of the OTCQX® marketplace reserved for high-quality, non-U.S. companies listed on a qualified stock exchange in their home country. U.S. investors can find current financial disclosures and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

"We are pleased LED Medical Diagnostics Inc. has chosen to trade on OTCQX," said R. Cromwell Coulson, President and CEO of OTC Markets Group. "OTCQX is the highest OTC marketplace offering qualifying companies like LED Medical Diagnostics the means to grow their U.S. shareholder base through high-quality disclosure, transparent trading and ease of access to company information."

"We are proud to join OTCQX," said Peter Whitehead, founder and CEO of LED Medical. "We are committed to providing our U.S. investors with timely news and information to help them better analyze, value and trade our securities."

Brean Capital, LLC will serve as LED Medical Diagnostics' Principal American Liaison ("PAL") on OTCQX, responsible for providing professional guidance on OTCQX requirements.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into marketplaces to better inform investors of opportunities and risks - OTCQX® - The Intelligent Marketplace for the Best OTC Companies; OTCQB® - The Venture Marketplace; and OTC Pink® - The Open Marketplace. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC registered ATS. Subscribe to the OTCQX RSS Feed.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc. is a leading developer of LED-based visualization technologies for the medical industry. The Company is currently listed on the Toronto Stock Exchange (TSX-V) under the symbol "LMD" and the Frankfurt Stock Exchange under the symbol "LME", and trades on OTCQX under the symbol "LEDIF".

Through its wholly-owned subsidiary, LED Dental Inc., the company manufactures the VELscope Vx® Enhanced Oral Assessment System, the first system in the world to apply tissue fluorescence visualization technology to the oral cavity. VELscope Vx® devices are now used to conduct more screenings for oral cancer and other oral tissue abnormalities than any other adjunctive device. To date, there have been more than 13,000 VELscope Vx® systems installed globally and they have been used to perform more than 25 million oral screenings. For more information, visit www.leddental.com.

Forward-Looking Information

This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Several factors could cause actual events or results to differ materially from those suggested by these forward-looking statements. Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2011. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:
LED Medical Diagnostics Inc.
Mark Komonoski, Investor Relations
(403) 255-8483 or Toll-Free: (877) 255-8483
Cell: (403) 470-8384
mark@komonoski.com / Skype: mkomonoski
www.leddental.com

OTC Markets Group Inc.
Saskia Sidenfaden
Media contact
+1 (212) 896-4428
saskia@otcmarkets.com
www.otcmarkets.com





Source: Marketwire


Story Tools